Cargando…
The Expression of Epac2 and GluA3 in an Alzheimer’s Disease Experimental Model and Postmortem Patient Samples
Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative diseases, characterized by amyloid beta (Aβ) and hyperphosphorylated tau accumulation in the brain. Recent studies indicated that memory retrieval, rather than memory formation, was impaired in the early stage of AD. Our previou...
Autores principales: | Zhang, Tong, Musheshe, Nshunge, van der Veen, Christina H. J. T. M., Kessels, Helmut W., Dolga, Amalia, De Deyn, Peter, Eisel, Ulrich, Schmidt, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452319/ https://www.ncbi.nlm.nih.gov/pubmed/37626593 http://dx.doi.org/10.3390/biomedicines11082096 |
Ejemplares similares
-
Pharmacological Inhibition of Epac1 Averts Ferroptosis Cell Death by Preserving Mitochondrial Integrity
por: Musheshe, Nshunge, et al.
Publicado: (2022) -
Synaptic plasticity through activation of GluA3-containing AMPA-receptors
por: Renner, Maria C, et al.
Publicado: (2017) -
The old second messenger cAMP teams up with novel cell death mechanisms: potential translational therapeutical benefit for Alzheimer’s disease and Parkinson’s disease
por: Zhang, Tong, et al.
Publicado: (2023) -
GluA3 subunits are required for appropriate assembly of AMPAR GluA2 and GluA4 subunits on cochlear afferent synapses and for presynaptic ribbon modiolar–pillar morphology
por: Rutherford, Mark A, et al.
Publicado: (2023) -
Targeting FRET-Based Reporters for cAMP and PKA Activity Using AKAP79
por: Musheshe, Nshunge, et al.
Publicado: (2018)